These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 1397775

  • 1. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat.
    Bravenboer B, Kappelle AC, Hamers FP, van Buren T, Erkelens DW, Gispen WH.
    Diabetologia; 1992 Sep; 35(9):813-7. PubMed ID: 1397775
    [Abstract] [Full Text] [Related]

  • 2. Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.
    Kappelle AC, Bravenboer B, van Buren T, Traber J, Erkelens DW, Gispen WH.
    Br J Pharmacol; 1993 Mar; 108(3):780-5. PubMed ID: 8467365
    [Abstract] [Full Text] [Related]

  • 3. Effect of honey and insulin treatment on oxidative stress and nerve conduction in an experimental model of diabetic neuropathy Wistar rats.
    Sirisha A, Gaur GS, Pal P, Bobby Z, Balakumar B, Pal GK.
    PLoS One; 2021 Mar; 16(1):e0245395. PubMed ID: 33449943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
    Qiang X, Satoh J, Sagara M, Fukuzawa M, Masuda T, Miyaguchi S, Takahashi K, Toyota T.
    Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
    [Abstract] [Full Text] [Related]

  • 7. Ranirestat Improved Nerve Conduction Velocities, Sensory Perception, and Intraepidermal Nerve Fiber Density in Rats with Overt Diabetic Polyneuropathy.
    Asano S, Himeno T, Hayami T, Motegi M, Inoue R, Nakai-Shimoda H, Miura-Yura E, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Kato K, Naruse K, Nakamura J, Kamiya H.
    J Diabetes Res; 2019 Aug; 2019():2756020. PubMed ID: 31828158
    [Abstract] [Full Text] [Related]

  • 8. Bimoclomol (BRLP-42) ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats.
    Bíró K, Jednákovits A, Kukorelli T, Hegedüs E, Korányi L.
    Brain Res Bull; 1997 Aug; 44(3):259-63. PubMed ID: 9323440
    [Abstract] [Full Text] [Related]

  • 9. ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats.
    Bravenboer B, Kappelle AC, van Buren T, Erkelens DW, Gispen WH.
    Acta Diabetol; 1993 Aug; 30(1):21-4. PubMed ID: 8392402
    [Abstract] [Full Text] [Related]

  • 10. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.
    Cotter MA, Dines KC, Cameron NE.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):534-40. PubMed ID: 7686634
    [Abstract] [Full Text] [Related]

  • 11. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.
    Obrosova IG, Fathallah L, Stevens MJ.
    Exp Neurol; 2001 Nov; 172(1):211-9. PubMed ID: 11681853
    [Abstract] [Full Text] [Related]

  • 12. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
    Davidson EP, Holmes A, Coppey LJ, Yorek MA.
    Eur J Pharmacol; 2015 Oct 15; 765():258-67. PubMed ID: 26291662
    [Abstract] [Full Text] [Related]

  • 13. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
    Saini AK, Kumar H S A, Sharma SS.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):164-72. PubMed ID: 17521626
    [Abstract] [Full Text] [Related]

  • 14. A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats.
    Moore SA, Peterson RG, Felten DL, O'Connor BL.
    J Neurol Sci; 1980 Oct 30; 48(1):133-52. PubMed ID: 6448276
    [Abstract] [Full Text] [Related]

  • 15. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.
    Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA.
    Diabetes Care; 1995 Aug 30; 18(8):1160-7. PubMed ID: 7587852
    [Abstract] [Full Text] [Related]

  • 16. Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy.
    Wada R, Nishizawa Y, Yagihashi N, Takeuchi M, Ishikawa Y, Yasumura K, Nakano M, Yagihashi S.
    Eur J Clin Invest; 2001 Jun 30; 31(6):513-20. PubMed ID: 11422401
    [Abstract] [Full Text] [Related]

  • 17. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH, Tomlinson DR.
    Diabetologia; 1983 Nov 30; 25(5):433-8. PubMed ID: 6197336
    [Abstract] [Full Text] [Related]

  • 18. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG, Kumar A, Sharma SS.
    Life Sci; 2006 Jul 17; 79(8):777-83. PubMed ID: 16581090
    [Abstract] [Full Text] [Related]

  • 19. [Effects of Tongluo recipe on experimental diabetic peripheral neuropathy in rats].
    Zhang DG, Zhao Y, Xia PJ, Huang XQ, Liu ZM, Zhou H.
    Zhong Xi Yi Jie He Xue Bao; 2006 Nov 17; 4(6):601-5. PubMed ID: 17090376
    [Abstract] [Full Text] [Related]

  • 20. High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats.
    van Dam PS, Bravenboer B, van Asbeck BS, Marx JJ, Gispen WH.
    Eur J Pharmacol; 1999 Jul 09; 376(3):217-22. PubMed ID: 10448879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.